Scaling-up of treatment of depression and anxiety - Authors' reply.
暂无分享,去创建一个
P. Cuijpers | F. Smit | P. Sheehan | S. Saxena | D. Chisholm | Bruce Rasmussen | K. Sweeny
[1] S. Saxena,et al. Cost effectiveness of strategies to combat neuropsychiatric conditions in sub-Saharan Africa and South East Asia: mathematical modelling study , 2012, BMJ : British Medical Journal.
[2] P. Cuijpers,et al. Scaling-up treatment of depression and anxiety: a global return on investment analysis. , 2016, The lancet. Psychiatry.
[3] H. Whiteford,et al. The burden of mental, neurological, and substance use disorders in China and India: a systematic analysis of community representative epidemiological studies , 2016, The Lancet.
[4] Dan J Stein,et al. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2015, The Lancet.